Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MEDIVAC

Financiado

Cerrado

Machine learning software to design personalized neoantigen vaccines tailored to...

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems Cancer is arguably the most feared of all diseases, destroying lives regardless of the age of its victims. Immunotherapies are currently regarded as the most promising avenue to delivering the holy grail of medicine i.e. providing... ver más

31/10/2021

Innovasjon Norge

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-10-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Innovasjon Norge

2.20M€ | Lider

SELENA IBERIA

170.44K€ | Participante

Proyectos interesantes

MEDIVAC

Medical Technol...

Software

71K€ Cerrado

NeoIDC

Medical Technol...

Data Science

150K€ Cerrado

IJC2019-040617-I

Medical Technol...

Data Science

93K€ Cerrado

SPLITVAC

Medical Technol...

Data Science

173K€ Cerrado

DECOD-Ag

Medical Technol...

Data Science

3M€ Cerrado

INTACt

Medical Technol...

Data Science

150K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 30 meses Fecha Inicio: 2019-04-05
Fecha Fin: 2021-10-31

Líder del proyecto

Innovasjon Norge No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is arguably the most feared of all diseases, destroying lives regardless of the age of its victims. Immunotherapies are currently regarded as the most promising avenue to delivering the holy grail of medicine i.e. providing a cure for cancer. Despite their Nobel-winning status, personalisation of immunotherapies remains akey challenge to which no cost-effective solution currently exists. Current methods for identifying the immunogenic neoantigens required to design patient-specific cancer vaccines typically utilize next generation sequencing (NGS) analysis of DNA and RNA coupled with wet lab methods (e.g. spectroscopy). However, these approaches are time consuming to perform, expensive and not readily scalable–which currently prohibits the mass roll-out of personalised cancer vaccines. Despite the fact that intensive research has been dedicated to developing prediction algorithms which can identify immunogenic neoantigens from NGS data from tumor samples, their accuracy has not yet reached a competitive performance compared to wet lab methods. To bridge this gap, OncoImmunity (OI) has developed a comprehensive machine learning framework, trained using public and proprietary datasets to optimise performance. Once fed with patient NGS data from healthy and tumor tissue, OI’s algorithms identifies the most clinically relevant neoantigen candidates, with an unmatched accuracy (4-fold increase of prediction accuracy), which can be subsequently engineering into personalised vaccine cancer constructs. Considering the potential of personalised therapy within cancer immunotherapy, OI’s core technology meets all the requirements to become a key enabling technology, providing cost-effective, scalable and sensitive identification of clinically relevant targets for vaccine development. Thus, it has the potential to serve as a cornerstone to revolutionize the fight against cancer – while untapping an immense business opportunity to fuel our company’s growth.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores